STD Programs Cost-Effective in Reducing HIV-1 Incidence

Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

STD Programs Cost-Effective in Reducing HIV-1 Incidence

Reuters Health Information Services (12/19/97)

Abstract: To determine the impact of improving sexually transmitted disease treatment services on the rate of HIV infection, Richard Hayes and colleagues from the London School of Hygiene and Tropical Medicine randomly selected a cohort of 12,537 adults in six rural Tanzanian communities and calculated the total cost per HIV-1 infection averted and the cost per disability-adjusted life-year (DALY) saved. According to a report in the Lancet, over the course of two years--during which the team treated 11,632 cases of STDs--the incidence of HIV-1 infection was 1.16 percent in the intervention groups and 1.86 percent in the comparison groups. The researchers estimate that the program prevented 252 HIV-1 infections per year and the cost per DALY was $10.33. Given these results, the researchers suggest that a significant number of HIV infections could be prevented if STD prevention programs are improved.

971222
AD972334

Copyright © 1997 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.